Zoghbi Huda Y
- SEC CIK
- 0001681643
In the past year, 2 open-market sale filings worth $1.92M and no purchases.
Current role at each company
- REGN Regeneron Pharmaceuticals, Inc.Directoras of Aug 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.92M
- 2 filings
- Net
- −$1.92M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Zoghbi Huda Y as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 (view filing)4:14 PM ET | Aug 10 | 2 days | Zoghbi Huda YDirector | SSale | −800 | $800.00 | −$640.0K | −32.0%1.70K after | 10b5-1 |
| Feb 23, 2026 (view filing) | Feb 19 | 4 days | Zoghbi Huda YDirector | SSale | −1.64K | $781.33 | −$1.28M | −49.0%1.70K after | 11 lots10b5-1 |
| Jan 4, 2024 (view filing) | Jan 2 | 2 days | Zoghbi Huda YDirector | SSale | −1.12K | $900.00 | −$1.01M | −47.3%1.25K after | 10b5-1 |
| Oct 17, 2023 (view filing) | Oct 13 | 4 days | Zoghbi Huda YDirector | SSale | −1.00K | $850.00 | −$850.0K | −44.5%1.25K after | 10b5-1 |
| Mar 18, 2022 (view filing) | Mar 16 | 2 days | Zoghbi Huda YDirector | SSale | −2.00K | $675.00 | −$1.35M | −64.9%1.08K after | |
| Sep 15, 2021 (view filing) | Sep 13-14 | 2 days | Zoghbi Huda YDirector | SSale | −1.00K | $650.00 | −$650.0K | −52.9%891 after | 2 lots |